Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors & Rheumatoid arthritis (RA)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors are novel agents designed to suppress immune signaling pathways involved in inflammation and joint destruction in Rheumatoid arthritis (RA). Four IRAK4 inhibitors have entered clinical trials.
Wiese et al. 2020 Exp Opin Invest drugs 29: 475-482

Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis
Wiese et al. 2020 Exp Opin Invest drugs 29: 475-482
Review

7/1/2026